China Approves First-in-Class Bispecific ADC Iza-bren for Advanced Nasopharyngeal Carcinoma

First regulatory approval for iza-bren (BL-B01D1), a first-in-class EGFR×HER3 bispecific antibody-drug conjugate (ADC) Represents an important n...

June 24, 2026 | Wednesday | News
Indiana Unveils ‘BioHeartland Indiana’ to Showcase Its $125 Billion Bioscience Economy

New regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs. BIO Internat...

June 24, 2026 | Wednesday | News
Reimagining Biotech Manufacturing: Enabling Innovation Without Infrastructure Constraints

  BIO 2026, taking place June 22–25 at the San Diego Convention Center, comes at a pivotal moment for emerging biotech companies. While scienti...

June 23, 2026 | Tuesday | Interview
Influencing Early-Phase Success: How Ardena Is Helping Biotechs Turn Complex Science into Clinical Progress

As biotech innovators pursue increasingly complex therapies, the path from discovery to clinical proof of concept is becoming more challenging than ever. F...

June 23, 2026 | Tuesday | News
Kither Biotech Completes First-in-Human Phase 1 Trial of Inhaled Respiratory Therapy KIT2014

First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalati...

June 22, 2026 | Monday | News
Sanofi Wins Japan Approval for Subcutaneous Sarclisa in Multiple Myeloma

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including th...

June 22, 2026 | Monday | News
Jazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engagers for Solid Tumors

The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in potential option fees and milestone payments for any pr...

June 19, 2026 | Friday | News
Jetstream Venture Fund Secures Early Access to Rejuvenate Bio’s Longevity Gene Therapy Platform

Jetstream Venture Fund (Jetstream), an innovative interval fund dedicated to opening access to institutional-grade deal flow for a wider mainstream audienc...

June 18, 2026 | Thursday | News
Phenomenex Launches Luna Omega HILIC LC Columns to Advance High-Performance Separation of Polar Compounds

Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, announced th...

June 10, 2026 | Wednesday | News
Lupin Secures U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec™

Global pharmaceutical leader Lupin Limited  announced that the United States Food and Drug Administration (U.S. FDA) has approved its ranibizum...

June 09, 2026 | Tuesday | News
Advanced NanoTherapies Secures $31 Million Series B to Advance Dual-Drug Balloon Platform for Vascular Disease

Advanced NanoTherapies, Inc. (ANT), a clinical-stage medtech company dedicated to improving outcomes for patients with coronary and peripheral artery dis...

June 04, 2026 | Thursday | News
Zymo Research Launches End-to-End NGS Services Portfolio to Accelerate Genomic Discovery

Zymo Research, a global leader in genomics tools, announced the launch of Zymo Services, a dedicated portfolio of end-to-end next-generation sequencing (...

June 04, 2026 | Thursday | News
Skyhawk Reports 12-Month Clinical Improvement and 69% mHTT Reduction with SKY-0515 in Huntington's Disease

Twelve-month findings showed improvement in Composite Unified Huntington's Disease Rating Scale (cUHDRS) scores from baseline of +0.38, compared to an ex...

June 04, 2026 | Thursday | News
First Foundation Labs and Microsoft Join Forces to Accelerate Life Sciences R&D with Enterprise AI

First Foundation Labs (1FL), a life sciences AI company pioneering clinical and translational reasoning spun out of Luma Group, announced a collaboration...

June 04, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close